The research progress on the pathogenesis and Chinese medicine intervention of osteosarcoma based on signaling pathways
Affiliation:

1.Jiangxi University of Chinese Medicine;2.Nanchang Hongdu Hospital of Traditional Chinese Medicine

  • Article
  • | |
  • Metrics
  • |
  • Reference [56]
  • | | | |
  • Comments
    Abstract:

    Osteosarcoma (OS) is a common primary malignant tumor of bone tissue, with high mortality, disability, metastasis and recurrence rates. Its pathogenesis is complex, which seriously affects the quality of life of patients and brings a huge economic burden to families and society. Traditional Chinese medicine has the characteristics of "multi-target, multi-component and multi-pathway". In recent years, a large number of animal or cell model experimental studies have found that The mechanism of OS progression is related to Notch, MAPK, Wnt / β-catenin, PI3K/Akt, Hedgehog and nuclear transcription Nf-κb, transforming growth factor-β (TGF-β)/Smad(Smad) and signal transducer and activator of transcription (STAT) pathways are closely related. Traditional Chinese medicine (TCM) can affect the biological processes such as cell proliferation, migration, invasion, apoptosis and autophagy by interfering with the above signaling pathways to play an anti-tumor role. Based on the cell signaling pathway, this study expounds the role of the above signaling pathways in OS, and summarizes the research status of traditional Chinese medicine intervention in the prevention and treatment of OS at home and abroad in recent years, aiming to provide a reference for further research on the treatment of OS with traditional Chinese medicine, in order to provide new ideas for clinical treatment of OS.

    Reference
    [1] [] Hu Z, Wen S, Huo Z, Wang Q, et al. Current Status and Prospects of Targeted Therapy for Osteosarcoma. Cells. 2022 Nov 5;11(21):3507.
    [2] [] Panez-Toro I, Mu?oz-García J, Vargas-Franco JW, et al. Advances in Osteosarcoma. Curr Osteoporos Rep. 2023 Aug;21(4):330-343.
    [3] [] Sun Y, Zhang C, Fang Q, et al. Abnormal signal pathways and tumor heterogeneity in osteosarcoma. J Transl Med. 2023 Feb 9;21(1):99.
    [4] [] Beird HC, Bielack SS, Flanagan AM, et al. Nat Rev Dis Primers. 2022 Dec 8;8(1):77.
    [5] [] Sadykova LR, Ntekim AI, Muyangwa-Semenova M, et al. Epidemiology and Risk Factors of Osteosarcoma. Cancer Invest. 2020 May;38(5):259-269.
    [6] [] Bian J, Liu Y, Zhao X, et al. Research progress in the mechanism and treatment of osteosarcoma. Chin Med J (Engl). 2023 Oct 20;136(20):2412-2420.
    [7] [] El-Naggar AM, Clarkson PW, Negri GL, et al. HACE1 is a potential tumor suppressor in osteosarcoma. Cell Death Dis. 2019 Jan 8;10(1):21.
    [8] [] Zhang X, Qiu H, Li C, et al. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends. 2021 Nov 21;15(5):283-298.
    [9] [] Chang JL, Wang WY, Li YM, et al. Chinese Herbal Medicine for Osteosarcoma in the Mouse: A Systematic Review and Meta-Analysis. Chin J Integr Med. 2019 May;25(5):370-377.
    [10] [] 朱青,朱垚,赵一帆,等.骨肉瘤中医核心病机分析[J].陕西中医药大学学报,2024,47(02):22-26.
    [11] [] 刘前,商冠宁.基于“痰挟淤血,遂成窠囊”从调气散结,痰淤同治法论治骨肉瘤[J].辽宁医学杂志,2024,38(01):1-5.
    [12] [] Yang J, Nie J, Ma X, et al. Targeting PI3K in cancer: mechanisms and advances in clinical trials.?Mol Cancer.?2019;18:26.
    [13] [] Ji Z, Shen J, Lan Y, et al. Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. MedComm (2020). 2023 Jul 10;4(4):e308.
    [14] [] Chen Z, Yang H, Zhang Q, et al. Chelerythrine Inhibits Stemness of Cancer Stem-Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal. J Oncol. 2022 Sep 12;2022:6435431.
    [15] [] Jing D, Chen X, Zhang Z, et al. 2-Hydroxy-3-methylanthraquinone inhibits homologous recombination repair in osteosarcoma through the MYC-CHK1-RAD51 axis. Mol Med. 2023 Jan 30;29(1):15.
    [16] [] Wu H, Ma T, He M, et al. Cucurbitacin B modulates M2 macrophage differentiation and attenuates osteosarcoma progression via PI3K/AKT pathway. Phytother Res. 2024 Feb 27.
    [17] [] 肖世富. 基于PI3K/Akt信号通路调控骨肉瘤细胞凋亡探讨抑瘤汤抗骨肉瘤的机制[D].广西中医药大学,2023.
    [18] [] Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022 Jan 3;7(1):3.
    [19] [] Zhu S, Liu Y, Wang X, et al. lncRNA SNHG10 Promotes the Proliferation and Invasion of Osteosarcoma via Wnt/β-Catenin Signaling. Mol Ther Nucleic Acids. 2020 Oct 15;22:957-970.
    [20] [] Wei Z, Zheng D, Pi W, et al. Isoquercitrin restrains the proliferation and promotes apoptosis of human osteosarcoma cells by inhibiting the Wnt/β-catenin pathway. J Bone Oncol. 2023 Jan 3;38:100468.
    [21] [] Qi YB, Yang W, Si M, et al. Wnt/βcatenin signaling modulates piperinemediated antitumor effects on human osteosarcoma cells. Mol Med Rep. 2020 May;21(5):2202-2208.
    [22] [] Pang F, Ding S, Li N, et al. Gallic acid mediates tumor-suppressive effects on osteosarcoma through the H19-Wnt/β-catenin regulatory axis. J Orthop Translat. 2023 Jan 4;39:34-42.
    [23] [] Xie X, Li Y, Zhu H, et al. Melittin Inhibits Growth of Human Osteosarcoma 143B Cells through Induction of Apoptosis?via?Suppressing the Wnt/β-catenin Signaling Pathway. Anticancer Agents Med Chem. 2022;22(18):3172-3181.
    [24] [] Zhu H, Chen D, Xie X, et al. Melittin inhibits lung metastasis of human osteosarcoma: Evidence of wnt/β-catenin signaling pathway participation. Toxicon. 2021 Jul 30;198:132-142.
    [25] [] Zhang S, He L, Shang J, et al. Carvacrol Suppresses Human Osteosarcoma Cells via the Wnt/β-Catenin Signaling Pathway. Anticancer Agents Med Chem. 2022;22(9):1714-1722.
    [26] []李增,张瑞,张晓坚,等.石见穿多糖通过Wnt/β-catenin信号通路调控骨肉瘤细胞的迁移和侵袭[J].中成药,2020,42(09):2324-2328.
    [27] [] 刘俊良. 抑瘤汤通过IFITM1/Wnt/β-catenin信号通路调控骨肉瘤恶性增殖的机制研究[D].广西中医药大学,2023.
    [28] [] Guo YJ, Pan WW, Liu SB, et al. ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020 Mar;19(3):1997-2007.
    [29] [] Tsai HC, Cheng SP, Han CK, et al. Resistin enhances angiogenesis in osteosarcoma via the MAPK signaling pathway. Aging (Albany NY). 2019 Nov 13;11(21):9767-9777.
    [30] [] Cheng G, Gao F, Sun X, et al. Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP2/9 production via the p38 MAPK signaling pathway. Mol Med Rep. 2016 Oct;14(4):3199-205.
    [31] [] Zhu J, Yu W, Liu B, et al. Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis. 2017 Oct 12;8(10):e3113.
    [32] [] Zeng Z, Zhang H, Wang X, et al. Salvianolic acid B suppresses cell proliferation and induces apoptosis in osteosarcoma through p38-mediated reactive oxygen species generation. Oncol Lett. 2018 Feb;15(2):2679-2685.
    [33] [] Wang S, Li H, Chen S, et al. Andrographolide induces apoptosis in human osteosarcoma cells via the ROS/JNK pathway. Int J Oncol. 2020 Jun;56(6):1417-1428.
    [34] [] ?u?ur A, Filipovi? M, Flegar D, et al. Notch receptors and ligands in inflammatory arthritis - a systematic review. Immunol Lett. 2020 Jul;223:106-114.
    [35] [] Zhang Z, Wu W, Shao Z. NOTCH Signaling in Osteosarcoma. Curr Issues Mol Biol. 2023 Mar 8;45(3):2266-2283.
    [36] [] Zhang J, Li N, Lu S, et al. The role of Notch ligand Jagged1 in osteosarcoma proliferation, metastasis, and recurrence. J Orthop Surg Res. 2021 Mar 29;16(1):226.
    [37] [] Xu Y, Shu B, Tian Y, et al. Oleanolic acid induces osteosarcoma cell apoptosis by inhibition of Notch signaling. Mol Carcinog. 2018 Jul;57(7):896-902.
    [38] [] Dai G, Yu L, Yang J, et al. The synergistic antitumor effect of cinobufagin and cisplatin in human osteosarcoma cell line?in vitro?and?in vivo. Oncotarget. 2017 Jul 25;8(49):85150-85168.
    [39] [] 刘德国,徐天波,张颉鸿,等.知母皂苷AⅢ通过调节Notch信号通路调控骨肉瘤细胞增殖、凋亡和上皮间质转化的机制[J].浙江中西医结合杂志,2023,33(08):692-697+709.
    [40] [] Ingham PW. Hedgehog signaling. Curr Top Dev Biol. 2022;149:1-58.
    [41] [] Nam A, Song WJ, An JH, et al. Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines. Vet Comp Oncol. 2022 Dec;20(4):778-787.
    [42] [] Zhao Z, Jia Q, Wu MS, et al. Degalactotigonin, a Natural Compound from?Solanum nigrum L., Inhibits Growth and Metastasis of Osteosarcoma through GSK3β Inactivation-Mediated Repression of the Hedgehog/Gli1 Pathway. Clin Cancer Res. 2018 Jan 1;24(1):130-144.
    [43] [] Tan B, Yuan Z, Zhang Q, et al. The NF-κB pathway is critically implicated in the oncogenic phenotype of human osteosarcoma cells. J Appl Biomed. 2021 Dec;19(4):190-201.
    [44] [] Wang XZ, Zhang SF, Yang ZH, et al. Punicalagin suppresses osteosarcoma growth and metastasis by regulating NF-κB signaling. J Biol Regul Homeost Agents. 2020 Sep-Oct;34(5):1699-1708.
    [45] [] Xu N, Wang L, Fu S, et al. Resveratrol is cytotoxic and acts synergistically with NF-κB inhibition in osteosarcoma MG-63 cells. Arch Med Sci. 2020 Nov 13;17(1):166-176.
    [46] [] Ahmadi M, Valizadeh A, Bazavar M, et al. Investigating the Role of Quercetin in Increasing the Rate of Cisplatin-Induced Apoptosis Via the NF-κB Pathway in MG-63 Cancer Cells. Drug Res (Stuttg). 2022 Sep;72(7):385-389.
    [47] [] Larson C, Oronsky B, Carter CA, et al. TGF-beta: a master immune regulator. Expert Opin Ther Targets. 2020 May;24(5):427-438.
    [48] [] Choi SH, Myers J, Tomchuck S, et al. Oral TGF-βR1 inhibitor Vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity. Res Sq [Preprint]. 2023 Apr 3:rs.3.rs-2709282.
    [49] [] 马金祥,马金兰,马金华.镰形棘豆总黄酮通过TGF-β/Smad3通路抑制骨肉瘤MG63细胞EMT[J].重庆医学,2019,48(08):1284-1287.
    [50] [] Ye G, Jiao Y, Deng L, et al. Beauvericin suppresses the proliferation and pulmonary metastasis of osteosarcoma by selectively inhibiting TGFBR2 pathway. Int J Biol Sci. 2023 Aug 21;19(14):4376-4392.
    [51] [] Jiang X, Zhang Z, Song C, et al. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma. Chem Biol Interact. 2019 Jul 1;307:158-166.
    [52] [] Keremu A, Aimaiti A, Liang Z, et al.?Role of the HDAC6/STAT3 pathway in regulating PD‐L1 expression in osteosarcoma cell lines.?Cancer Chemother Pharmacol. 2019;83:255‐264.
    [53] [] Wang W, Li J, Ding Z, et al. Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway. J Cell Mol Med. 2019 Sep;23(9):6454-6465.
    [54] [] Tian L, Li C, Xiang L, et al. T52 attenuates oncogenic STAT3 signaling and suppresses osteosarcoma. Phytomedicine. 2023 Jun;114:154799.
    [55] []刘莹.清化复肝汤防治骨肉瘤甲氨蝶呤化疗性肝损伤的临床研究[J].现代中西医结合杂志,2020,29(27):3047-3049+3053.
    [56] [] Zhang FW, Peng LY, Shi CJ, et al. Baicalein mediates the anti-tumor activity in Osteosarcoma through lncRNA-NEF driven Wnt/β-catenin signaling regulatory axis. J Orthop Translat. 2022 Mar 11;33:132-141.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation
Share
Article Metrics
  • Abstract:55
  • PDF: 0
  • HTML: 0
  • Cited by: 0
History
  • Received:September 26,2024
  • Revised:November 13,2024
  • Adopted:May 06,2025
Article QR Code